Equities

Acutus Medical Inc

AFIB:PKC

Acutus Medical Inc

Actions
  • Price (USD)0.10
  • Today's Change0.02 / 25.00%
  • Shares traded518.79k
  • 1 Year change-83.87%
  • Beta0.0205
Data delayed at least 15 minutes, as of Sep 20 2024 20:54 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Acutus Medical Inc had net income fall 106.14% from a loss of 39.62m to a larger loss of 81.66m despite a 136.36% increase in revenues from 3.03m to 7.16m.
Gross margin-24.07%
Net profit margin-101.56%
Operating margin-73.65%
Return on assets-12.30%
Return on equity-34.35%
Return on investment-14.84%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Acutus Medical Inc fell by 5.15m. However, Cash Flow from Investing totalled 58.56m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 63.12m for operations while cash used for financing totalled 2.66m.
Cash flow per share-0.3213
Price/Cash flow per share--
Book value per share-0.1353
Tangible book value per share-0.1353
More ▼

Balance sheet in USDView more

Acutus Medical Inc has a Debt to Total Capital ratio of 113.14%, a higher figure than the previous year's 57.10%.
Current ratio3.48
Quick ratio2.89
Total debt/total equity--
Total debt/total capital1.13
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.